Optimalisation of tablet formula from chlorophyll of Sauropus androgynus (L.) Merr. leaves using simplex lattice design (SLD)

Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition o...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy & pharmacognosy research Vol. 13; no. 2; pp. 591 - 596
Main Authors Suparmi, Suparmi, Latifah, Fadzil, Lestanu, Lucky April, Fasitasari, Minidian, Rustanti, Ninik
Format Journal Article
LanguageEnglish
Published 01.03.2025
Online AccessGet full text

Cover

Loading…
Abstract Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition of the optimum excipient with variations in magnesium stearate and microcrystalline cellulose (MCC) concentrations and evaluate the physical properties of the tablet formula of chlorophyll S. androgynus leaves. Methods: S. androgynus chlorophyll tablets were formulated using the direct compression method. The dose of S. androgynus chlorophyll was converted from the effective dose of antianaemia in rats of 0.016 mg/200 g BW to the human dose of 0.896 mg. A simplex lattice design (SLD) was adopted to optimize the eight formulations. Results: SLD can be used to optimize the concentrations of magnesium stearate and MCC in the tablet formulation from S. androgynus chlorophyll. The 5% magnesium stearate formula and 20% MCC had the highest uniformity and disintegration time. The relative concentration of magnesium stearate and MCC influence the thickness, weight, hardness, friability, and disintegration time of the tablets produced. Conclusions: The 5% magnesium stearate formula and 20% MCC had the shortest disintegration time and can be considered the optimum formula for tablets from S. androgynus chlorophyll. Further study on the beneficial and toxic effects of tablets from S. androgynus chlorophyll would be very beneficial in preventing iron deficiency anaemia.
AbstractList Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient composition affects the physical properties and therapy effectiveness of tablets from S. androgynus chlorophyll. Aims: To determine the composition of the optimum excipient with variations in magnesium stearate and microcrystalline cellulose (MCC) concentrations and evaluate the physical properties of the tablet formula of chlorophyll S. androgynus leaves. Methods: S. androgynus chlorophyll tablets were formulated using the direct compression method. The dose of S. androgynus chlorophyll was converted from the effective dose of antianaemia in rats of 0.016 mg/200 g BW to the human dose of 0.896 mg. A simplex lattice design (SLD) was adopted to optimize the eight formulations. Results: SLD can be used to optimize the concentrations of magnesium stearate and MCC in the tablet formulation from S. androgynus chlorophyll. The 5% magnesium stearate formula and 20% MCC had the highest uniformity and disintegration time. The relative concentration of magnesium stearate and MCC influence the thickness, weight, hardness, friability, and disintegration time of the tablets produced. Conclusions: The 5% magnesium stearate formula and 20% MCC had the shortest disintegration time and can be considered the optimum formula for tablets from S. androgynus chlorophyll. Further study on the beneficial and toxic effects of tablets from S. androgynus chlorophyll would be very beneficial in preventing iron deficiency anaemia.
Author Fasitasari, Minidian
Suparmi, Suparmi
Lestanu, Lucky April
Latifah, Fadzil
Rustanti, Ninik
Author_xml – sequence: 1
  givenname: Suparmi
  orcidid: 0000-0001-7914-870X
  surname: Suparmi
  fullname: Suparmi, Suparmi
– sequence: 2
  givenname: Fadzil
  orcidid: 0009-0004-6041-1706
  surname: Latifah
  fullname: Latifah, Fadzil
– sequence: 3
  givenname: Lucky April
  surname: Lestanu
  fullname: Lestanu, Lucky April
– sequence: 4
  givenname: Minidian
  orcidid: 0000-0003-4797-4745
  surname: Fasitasari
  fullname: Fasitasari, Minidian
– sequence: 5
  givenname: Ninik
  orcidid: 0000-0002-8308-8057
  surname: Rustanti
  fullname: Rustanti, Ninik
BookMark eNqdjz1PwzAYhC1UJAr0N_CO7VBjO0mjzHyIoYih7JZJ7dSVY1t-HUQG_jsBFYmZ6e6kO-meSzLzwWtCbjij1aZsmttjjEmjKKngopC8oIJWDT8jc1bzZl2Kis3--AuyQDwyxni9KYuaz8nnS8y2V86iyjZ4CAayenM6gwmpH5wCk0IP7cGFFOJhdO67slPDlAYE5fcpdKOf7HJLV_CsU6LgtHrXCANa3wHaPjr9AU7lbFsNe42287Dcbe9X1-TcKId6cdIrUj8-vN49rdsUEJM2MqbpXRolZ_IHWP4CyxOwFHICLv6__AKhm2bM
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.56499/jppres24.2123_13.2.591
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 0719-4250
EndPage 596
ExternalDocumentID 10_56499_jppres24_2123_13_2_591
GroupedDBID 5VS
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BCNDV
CITATION
GROUPED_DOAJ
GX1
HH5
KQ8
M~E
OK1
ID FETCH-crossref_primary_10_56499_jppres24_2123_13_2_5913
ISSN 0719-4250
IngestDate Wed Nov 13 12:40:15 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-crossref_primary_10_56499_jppres24_2123_13_2_5913
ORCID 0000-0003-4797-4745
0000-0002-8308-8057
0000-0001-7914-870X
0009-0004-6041-1706
ParticipantIDs crossref_primary_10_56499_jppres24_2123_13_2_591
PublicationCentury 2000
PublicationDate 2025-3-1
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-3-1
  day: 01
PublicationDecade 2020
PublicationTitle Journal of pharmacy & pharmacognosy research
PublicationYear 2025
SSID ssj0001764371
Score 4.688427
Snippet Context: Sauropus androgynus (L) Merr, known as a sweet leaf, contains chlorophyll, potentially an antioxidant. The selection of appropriate excipient...
SourceID crossref
SourceType Aggregation Database
StartPage 591
Title Optimalisation of tablet formula from chlorophyll of Sauropus androgynus (L.) Merr. leaves using simplex lattice design (SLD)
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5F5cIFQQviWc0BVa1Sm_ixdnpEQFShBColSL1Za3dNLYIdObZEKvGD-RfM7K4fLZEgXCxnnR15PZ9nZ8ffzDL22pOh9JIRtwIvlJbPXbSD3lhaY8ETLtE_T1Sd7dmn4PyL__GSXw4Gv3qspbqK7eRma17J_2gV21CvlCW7g2ZbodiA56hfPKKG8fhPOv6M7_t3qmDY-n0VZUJVKiWxXgqdPJJc45q8wMe5VH7nXFAAvla1mcvi6yavVeB1SglXw5ksS5u2kqBitLWKI6wzKiD8Y7gUFRHlhleK80Fd5tP3TSDhT_d2pWtia0KO-VEQq28zNAWG2kD0vF7h5UyThNRpSxPCgaVCRX4m4uqmo4NMJXm1tYoq1Mm3DXrTZXd1ItZZJdZCZ9HPsjxr3wIT4HB5x_AydjB0ziw0LfrzjdzS1hhyrwdYt2eVud4QzEzwXG-he3fu4AEu_mjyWBED2fVtmtQjx7Ndu-3fr9Z9ZxZtuY24qlKiokZQZARFbsSpzsI9F21i0Fv9q3BgSF9Q1f6OzdA0G1HJerP9pnq-VM8pWjxkD4y64a2G5iM2kPk-O7owqj-FRZfdtz6FI7joCqVvDtjP2_iFIgWNXzD4BcIv9PBLf2nwCx1-4Xhqn4DCLmjsgsIuGOyCwS5o7MIxIvfkMQsnHxbvzq1mcNFKV16J_vJsvSdsLy9y-ZRBnLoCfW8ndHzpp14Qp07oiTNajstRMo6fsdGu0p_v3uUFu98h-iXbq8pavkIntooPlfp_A7YHo8Y
link.rule.ids 315,783,787,867,27936,27937
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimalisation+of+tablet+formula+from+chlorophyll+of+Sauropus+androgynus+%28L.%29+Merr.+leaves+using+simplex+lattice+design+%28SLD%29&rft.jtitle=Journal+of+pharmacy+%26+pharmacognosy+research&rft.au=Suparmi%2C+Suparmi&rft.au=Latifah%2C+Fadzil&rft.au=Lestanu%2C+Lucky+April&rft.au=Fasitasari%2C+Minidian&rft.date=2025-03-01&rft.issn=0719-4250&rft.eissn=0719-4250&rft.volume=13&rft.issue=2&rft.spage=591&rft.epage=596&rft_id=info:doi/10.56499%2Fjppres24.2123_13.2.591&rft.externalDBID=n%2Fa&rft.externalDocID=10_56499_jppres24_2123_13_2_591
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0719-4250&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0719-4250&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0719-4250&client=summon